When the GLP-1 receptor is activated across these systems, several metabolic processes occur: Improved insulin sensitivity Better glucose uptake by cells Reduced excessive glucagon production Enhanced satiety signaling to the brain More stable energy levels after meals Together, these changes create a metabolic environment that supports efficient energy usage rather than excess energy storage
Stay active Walking, cycling, swimming, or other regular physical activities promote healthy digestion and regular bowel movements
No other peptide in development has matched these numbers
Programs that can offer both, along with oral and injectable formats, give patients more room to find what actually works for their body
Glucose-Dependent Insulinotropic Polypeptide (GIP) Receptor Agonism: This component acts synergistically with GLP-1
Drugs 78(11):11131132 dAquino AI, Maikawa CL, Nguyen LT, Lu K, Hall IA, Jons CK, et al (2023) Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes management